SCHEMBL30796719

SCHEMBL30796719

Nc1nnc(-c2cccc(F)c2O)cc1N1C[C@H]2CC[C@@H](C1)N2c1nccc(C2CCN(C(=O)OCc3ccccc3)CC2)n1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 5/20 0.43
▸ SMARCA4 P51532 5/20 0.43
▸ PBRM1 Q86U86 7/20 0.37
▸ TRPC3 Q13507 2/20 0.37
▸ TRPC7 Q9HCX4 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ GRIN2B Q13224 4/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ HDAC1 Q13547 1/20 0.34
▸ TMEM97 Q5BJF2 1/20 0.34
▸ SIGMAR1 Q99720 1/20 0.34
▸ GUCY1A1 Q02108 1/20 0.34
▸ GUCY1B1 Q02153 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30797146 0.86 TRPC3 (0.43) SMARCA2SMARCA4TRPC3TRPC7SMN1; SMN2
SCHEMBL30796877 0.82 SMARCA2 (0.47) SMARCA2SMARCA4PBRM1
SCHEMBL29943535 0.79 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1
SCHEMBL30797042 0.77 SMARCA2 (0.51) SMARCA2SMARCA4PBRM1HDAC1
SCHEMBL30797014 0.77 SMARCA2 (0.51) SMARCA2SMARCA4PBRM1HDAC1
SCHEMBL30796207 0.76 SMARCA2 (0.51) SMARCA2SMARCA4PBRM1SMN1; SMN2
SCHEMBL27458085 0.75 SMARCA2 (0.48) SMARCA2SMARCA4PBRM1
SCHEMBL23301217 0.75 PBRM1 (0.52) SMARCA2SMARCA4PBRM1SMN1; SMN2CYP2C19
SCHEMBL30796712 0.74 SMARCA2 (0.59) SMARCA2SMARCA4PBRM1
SCHEMBL27458561 0.74 SMARCA2 (0.59) SMARCA2SMARCA4PBRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4539849-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 Therapeutics, Inc. (US) 2025-04-23 — — EP disclosed
WO-2023244764-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 THERAPEUTICS, INC. (US) 2023-12-21 — — WO disclosed
Send feedback